MC1597A1 - Derives d'isoquinoleine substitues - Google Patents

Derives d'isoquinoleine substitues

Info

Publication number
MC1597A1
MC1597A1 MC841707A MC1707A MC1597A1 MC 1597 A1 MC1597 A1 MC 1597A1 MC 841707 A MC841707 A MC 841707A MC 1707 A MC1707 A MC 1707A MC 1597 A1 MC1597 A1 MC 1597A1
Authority
MC
Monaco
Prior art keywords
methyl
dimethoxy
dimethoxyphenyl
formula
compound
Prior art date
Application number
MC841707A
Other languages
English (en)
French (fr)
Inventor
Hans Bruderer
Richard-Wightman Kierstead
Jr John G Mullin
Keiji Nakamua
Jay-Philip O'brien
Mitsuru Tateishi
Sidney Teitel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1597A1 publication Critical patent/MC1597A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
MC841707A 1983-05-19 1984-05-17 Derives d'isoquinoleine substitues MC1597A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/496,327 US4544657A (en) 1983-05-19 1983-05-19 Substituted isoquinolines

Publications (1)

Publication Number Publication Date
MC1597A1 true MC1597A1 (fr) 1985-05-09

Family

ID=23972146

Family Applications (1)

Application Number Title Priority Date Filing Date
MC841707A MC1597A1 (fr) 1983-05-19 1984-05-17 Derives d'isoquinoleine substitues

Country Status (20)

Country Link
US (1) US4544657A (cg-RX-API-DMAC7.html)
EP (1) EP0126480B1 (cg-RX-API-DMAC7.html)
JP (1) JPS59222478A (cg-RX-API-DMAC7.html)
KR (1) KR840009102A (cg-RX-API-DMAC7.html)
AT (1) ATE32072T1 (cg-RX-API-DMAC7.html)
AU (1) AU570044B2 (cg-RX-API-DMAC7.html)
CA (1) CA1243028A (cg-RX-API-DMAC7.html)
DE (1) DE3468875D1 (cg-RX-API-DMAC7.html)
DK (1) DK248484A (cg-RX-API-DMAC7.html)
ES (1) ES532603A0 (cg-RX-API-DMAC7.html)
FI (1) FI81795C (cg-RX-API-DMAC7.html)
GR (1) GR82015B (cg-RX-API-DMAC7.html)
HU (1) HU192555B (cg-RX-API-DMAC7.html)
IL (1) IL71860A (cg-RX-API-DMAC7.html)
MC (1) MC1597A1 (cg-RX-API-DMAC7.html)
NO (1) NO159271C (cg-RX-API-DMAC7.html)
NZ (1) NZ208186A (cg-RX-API-DMAC7.html)
PH (1) PH19670A (cg-RX-API-DMAC7.html)
PT (1) PT78618A (cg-RX-API-DMAC7.html)
ZA (1) ZA843748B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124511C1 (ru) * 1993-05-14 1999-01-10 Фармасьютикал Ко., Лтд Производные пиперазина
US5681954A (en) * 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
EP0784474A2 (en) * 1994-10-05 1997-07-23 Glaxo Wellcome Inc. Parenteral pharmaceutical compositions containing gf120918a
FR2840896B1 (fr) * 2002-06-18 2005-04-08 Sanofi Synthelabo Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
BRPI0614692A2 (pt) 2005-07-29 2009-05-19 Hoffmann La Roche derivados de indol-3-il-carbonil-piperidina e piperazina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759443A (fr) * 1970-09-15 1971-04-30 I F L O Istituto Farmacologico Nouveau derive papaverolinique et procede de preparation relatif
DE2818423A1 (de) * 1978-04-27 1979-11-08 Hoechst Ag Neue isochinolinderivate und verfahren zu ihrer herstellung
FI802117A7 (fi) * 1979-07-19 1981-01-01 Andre Buzas Menetelmä papaveriini-karbanionin valmistamiseksi.
DE3034001A1 (de) * 1980-09-10 1982-04-22 Hoechst Ag, 6000 Frankfurt Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung

Also Published As

Publication number Publication date
US4544657A (en) 1985-10-01
FI81795B (fi) 1990-08-31
CA1243028A (en) 1988-10-11
AU2835684A (en) 1984-11-22
ATE32072T1 (de) 1988-02-15
DE3468875D1 (en) 1988-02-25
JPS59222478A (ja) 1984-12-14
PH19670A (en) 1986-06-09
FI841992A0 (fi) 1984-05-17
ES8601141A1 (es) 1985-11-01
IL71860A (en) 1987-10-30
NO842003L (no) 1984-11-20
HUT34185A (en) 1985-02-28
KR840009102A (ko) 1984-12-24
HU192555B (en) 1987-06-29
EP0126480B1 (de) 1988-01-20
PT78618A (en) 1984-06-01
AU570044B2 (en) 1988-03-03
FI81795C (fi) 1990-12-10
ES532603A0 (es) 1985-11-01
ZA843748B (en) 1985-01-30
NO159271B (no) 1988-09-05
FI841992A7 (fi) 1984-11-20
EP0126480A1 (de) 1984-11-28
NO159271C (no) 1988-12-14
IL71860A0 (en) 1984-09-30
DK248484D0 (da) 1984-05-17
DK248484A (da) 1984-11-20
NZ208186A (en) 1987-06-30
GR82015B (cg-RX-API-DMAC7.html) 1984-12-12

Similar Documents

Publication Publication Date Title
EP0307303B1 (fr) [(Pyrimidinyl-2)-aminoalkyl]-1 pipéridines, leur préparation et leur application en thérapeutique
US4647561A (en) 1,5-benzodiazepine compounds
EP0306375A1 (fr) Dérivés de[(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique
MC1769A1 (fr) Diphenaylpiperidines n-substituees
EP1638943B1 (fr) NOUVEAUX DERIVES D’IMIDAZOLES, LEUR PREPARATION ET LEUR UTILISATION EN TANT QUE MEDICAMENT
KR840001552B1 (ko) 시클로헥센 유도체의 제조방법
EP0816338B1 (en) 3-(bis-substituted-phenylmethylene)oxindole derivatives
MC1597A1 (fr) Derives d'isoquinoleine substitues
FR2618150A1 (fr) Benzazepines 3-substituees a action therapeutique
EP0269599A2 (fr) 1H-Imidazoles substitués
MC511A1 (fr) Nouveaux composés hétérocycliques et leur préparation
EP0301936A1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
EP1828125B1 (fr) Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine
JP3588363B2 (ja) キノキサリンジオン類
EP0077083A1 (fr) Nouveaux dérivés de la thioformamide, leur préparation et les médicaments qui les contiennent
JPH02290855A (ja) ベンズアゼピン誘導体
CH666689A5 (fr) Derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine, leur preparation et compositions therapeutiques a base de ceux-ci.
FR2551753A2 (fr) Benzotriazine-1,2,3-ones-4, procede de preparation et medicaments les contenant
EP0351283A1 (fr) Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique
EP0173634A1 (fr) Nouveaux dérivés d'(arylpipérazinyléthylaminoéthoxy)-4 phénol, leur méthode de préparation et leur application thérapeutique
EP0275759B1 (fr) 3-pipéridineamines ou 3-azépineamines substituées, leur préparation et leurs applications en thérapeutique
EP0099822B1 (fr) Nouveaux 1-(2-carbalkoxy 4-(thiénylalkylamido)phénoxy) 3-amino 2-propanols, leur préparation et leurs applications en thérapeutique
KR820001835B1 (ko) 4-아미노-2-피페리디노퀴나졸린 유도체의 제조방법
CA1253145A (en) Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
EP0986552A1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
YP Annual fee paid